We are live on
!
Find out more
WP
Waycross Partners Portfolio holdings
AUM
$1.05B
1-Year Est. Return
20.92%
This Fund
S&P 500
This Quarter
Est. Return
-3.31%
1 Year Est. Return
+20.92%
3 Year Est. Return
+78.91%
5 Year Est. Return
+114.23%
10 Year Est. Return
–
AUM
$172M
AUM Growth
-$3.07M
(-1.8%)
Cap. Flow
+$5.69M
Cap. Flow
% of AUM
3.32%
Top 10 Holdings %
Top 10 Hldgs %
35.52%
Holding
92
New
7
Increased
36
Reduced
9
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caterpillar
CAT
|
+$2.87M |
| 2 |
Advanced Micro Devices
AMD
|
+$2.39M |
| 3 |
Netflix
NFLX
|
+$2.21M |
| 4 |
JPMorgan Chase
JPM
|
+$2.15M |
| 5 |
FedEx
FDX
|
+$2.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$4.05M |
| 2 |
Procter & Gamble
PG
|
+$2.47M |
| 3 |
Medtronic
MDT
|
+$1.73M |
| 4 |
Royal Caribbean
RCL
|
+$1.54M |
| 5 |
Nutrien
NTR
|
+$1.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.99% |
| 2 | Healthcare | 16.98% |
| 3 | Consumer Discretionary | 16.35% |
| 4 | Financials | 13.55% |
| 5 | Industrials | 13.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FISV
76
Fiserv Inc
FISV
$29.7B
| $385K | 0.22% |
+3,800
| New | +$385K |
|
77
Bristol-Myers Squibb
BMY
$130B
| $333K | 0.19% |
4,557
| – | – |
|
78
Johnson & Johnson
JNJ
$641B
| $301K | 0.18% |
1,700
| – | – |
|
79
Align Technology
ALGN
$13B
| $218K | 0.13% |
500
| – | – |
|
80
Celanese
CE
$4.79B
| – | – |
-7,000
| Closed | -$1.18M |
|
81
Guardant Health
GH
$19.4B
| – | – |
-2,800
| Closed | -$280K |
|
82
General Motors
GM
$82.1B
| – | – |
-19,600
| Closed | -$1.15M |
|
83
Humana
HUM
$43.3B
| – | – |
-1,000
| Closed | -$464K |
|
84
Johnson Controls International
JCI
$85.4B
| – | – |
-18,000
| Closed | -$1.46M |
|
85
lululemon athletica
LULU
$13.6B
| – | – |
-3,211
| Closed | -$1.26M |
|
86
Southwest Airlines
LUV
$22.3B
| – | – |
-30,000
| Closed | -$1.28M |
|
|
87
Medtronic
MDT
$113B
| – | – |
-16,673
| Closed | -$1.73M |
|
|
88
Nutrien
NTR
$33.7B
| – | – |
-20,000
| Closed | -$1.5M |
|
|
89
Royal Caribbean
RCL
$87.3B
| – | – |
-20,000
| Closed | -$1.54M |
|
90
SLB Ltd
SLB
$73.3B
| – | – |
-37,300
| Closed | -$1.12M |
|
91
Viatris
VTRS
$20.9B
| – | – |
-75,280
| Closed | -$1.02M |
|
|
XLNX
92
DELISTED
Xilinx Inc
XLNX
| – | – |
-19,111
| Closed | -$4.05M |
|
Similar funds
LPC
HWCM
AA
CIA
CIA
SPC
LAM
CA
Waycross Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Waycross Partners held 92 positions worth $172M, down 1.8% from $175M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Waycross Partners deployed $5.69M of net new capital in Q1 2022, opening 7 new positions and adding to 36 existing holdings. Its largest new stake was Advanced Micro Devices: 20,000 shares worth $2.19M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Procter & Gamble, an estimated $2.47M trimmed.
- Waycross Partners's largest Q1 2022 buy was Advanced Micro Devices: 20,000 shares worth $2.19M.
- Waycross Partners added most to Caterpillar in Q1 2022, an estimated $2.87M increase.
- Waycross Partners's biggest Q1 2022 reduction was Procter & Gamble, cutting an estimated $2.47M.
- Waycross Partners fully exited Xilinx Inc in Q1 2022, selling an estimated $4.05M.
- Waycross Partners's ten largest holdings make up 36% of its $172M portfolio in Q1 2022.
- Waycross Partners opened 7 new positions and closed 13 in Q1 2022.
- Waycross Partners's portfolio value fell 1.8% quarter-over-quarter to $172M.
Based on Waycross Partners's 13F filing for Q1 2022, filed 29 Apr 2022.